Acceleron Pharma Stock Total Asset
Acceleron Pharma fundamentals help investors to digest information that contributes to Acceleron Pharma's financial success or failures. It also enables traders to predict the movement of Acceleron Stock. The fundamental analysis module provides a way to measure Acceleron Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Acceleron Pharma stock.
Acceleron |
Acceleron Pharma Company Total Asset Analysis
Acceleron Pharma's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Acceleron Pharma Total Asset | 146.34 M |
Most of Acceleron Pharma's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Acceleron Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Acceleron Pharma has a Total Asset of 146.34 M. This is 98.05% lower than that of the Healthcare sector and 92.59% lower than that of the Biotechnology industry. The total asset for all United States stocks is 99.5% higher than that of the company.
Acceleron Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Acceleron Pharma's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Acceleron Pharma could also be used in its relative valuation, which is a method of valuing Acceleron Pharma by comparing valuation metrics of similar companies.Acceleron Pharma is currently under evaluation in total asset category among related companies.
Acceleron Fundamentals
| Return On Equity | -29.16 | |||
| Return On Asset | -16.73 | |||
| Profit Margin | (158.11) % | |||
| Operating Margin | (158.79) % | |||
| Current Valuation | 6.93 B | |||
| Shares Outstanding | 60.7 M | |||
| Shares Owned By Insiders | 11.86 % | |||
| Shares Owned By Institutions | 90.60 % | |||
| Number Of Shares Shorted | 2.12 M | |||
| Price To Earning | (14.74) X | |||
| Price To Book | 13.44 X | |||
| Price To Sales | 96.57 X | |||
| Revenue | 112.94 M | |||
| Gross Profit | (81.39 M) | |||
| EBITDA | (175.46 M) | |||
| Net Income | (178.56 M) | |||
| Cash And Equivalents | 687.25 M | |||
| Cash Per Share | 11.32 X | |||
| Total Debt | 22.43 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 14.81 X | |||
| Book Value Per Share | 13.37 X | |||
| Cash Flow From Operations | (151.71 M) | |||
| Short Ratio | 6.39 X | |||
| Earnings Per Share | (3.05) X | |||
| Number Of Employees | 312 | |||
| Beta | 0.35 | |||
| Market Capitalization | 10.91 B | |||
| Total Asset | 146.34 M | |||
| Retained Earnings | (381.51 M) | |||
| Working Capital | 96.44 M | |||
| Current Asset | 110.93 M | |||
| Current Liabilities | 14.49 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Acceleron Stock
If you are still planning to invest in Acceleron Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acceleron Pharma's history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |